340binformed.org

Your Free Source for 340B News and Commentary

  • About us
  • Advertise
  • Contact
  • 340B Health

Hospitals Share Concerns About HRSA’s 340B Guidance with Congress

Changes will harm their ability to care for vulnerable patients 

November 20, 2015—Proposed 340B drug discount policy changes – especially those affecting discharge prescriptions, physician eligibility, and infusion drugs – will jeopardize hospitals' ability to care for vulnerable patients if the government finalizes them as is, hospital leaders warned at a Capitol Hill briefing yesterday. … [Read more...]

HHS Holds Forum on Rising Drug Prices

Manufacturers say insurers and providers deserve a closer look for their role 

November 20, 2015—U.S. Health and Human Services Secretary Sylvia Mathews Burwell today opened a forum on the high and growing cost of prescription drugs with a challenge to government agencies, pharmaceutical manufacturers, patient advocates, providers, employers, and payers to come together "to find a path that doesn’t ask us to choose between innovation and affordability." … [Read more...]

Drugmakers Seek Big Changes to 340B Mega-guidance

PhRMA and BIO say HRSA needs to do more to rein program in 

November 20, 2015—Brand-name drug and biotech companies are pleased with parts of the proposed 340B program guidance that would raise the prices hospitals pay for drugs. But in their comments to the Health Resources and Services Administration, the two main trade groups for branded drug manufacturers say the guidance doesn't go far enough. … [Read more...]

AMA Calls for Ban on Consumer Drug Advertising

Part of new policy aimed at making prescription drugs more affordable 

November 20, 2015—The American Medical Association called for a ban on direct-to-consumer advertising for prescription drugs and medical devices at the group’s annual meeting in Atlanta. … [Read more...]

Orphan Drugs Approaching 20 Percent of Pharmaceutical Sales

Recent court decision foreclosed 340B discounts for rural, cancer hospitals 

November 11, 2015—The biopharmaceutical industry's affinity for orphan drugs keeps growing, with orphans projected to account for 20.2 percent of all prescription drug sales worldwide by 2020 – up from 11.2 percent in 2010 and 6.1 percent in 2000, a new study shows. … [Read more...]

Key Committee Chair Rep. Joe Pitts to Retire in 2016

Lawmaker has concerns about clarity of 340B program rules, oversight 

November 10, 2015—Rep. Joe Pitts (R-Pa.), the chairman of the House subcommittee with primary jurisdiction over the 340B program, is retiring from Congress when his current term ends in 2016. … [Read more...]

OIG Plans to Issue Two Studies on 340B in FY 2016

Topics are Part B reimbursement and Medicaid managed care duplicate discounts 

November 5, 2015—The Department of Health and Human Services Inspector General plans to issue a pair of reports about the 340B program this fiscal year. … [Read more...]

« Previous Page
Next Page »

LATEST ARTICLES DELIVERED

Get new article alerts via email.

This field is required.

Check your inbox or spam folder now to confirm your subscription.

FOLLOW | SHARE | LIKE

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

340B Health Twitter

Twitter feed is not available at the moment.

RSS feed: 340B Employed 340B Employed

  • 340B Program Compliance Analyst Certified | UNC Health November 17, 2026
  • 340B Program Compliance Analyst Certified | UNC Health November 17, 2026
  • 340B Program Specialist | Vail Health November 17, 2026
  • Pharmacy Manager, 340B Program | Tufts Medical Center November 11, 2026
  • 340B Program Pharmacy Manager | Allies for Health + Wellbeing November 10, 2026

Copyright © 2026 · 340B Health